albuterol sulfate inhalation aerosol

Phase 3Small molecule

albuterol sulfate inhalation aerosol is one of 68 small molecule programs targeting Chronic Obstructive Pulmonary Disease. It is currently in Phase 3.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Chronic Obstructive Pulmonary DiseaseActive, not recruiting

WheezingActive, not recruiting

AsthmaActive, not recruiting

Chronic Obstructive Pulmonary DiseasePhase 2

Active, not recruiting

WheezingPhase 3

Active, not recruiting

AsthmaPhase 3

Active, not recruiting

Competition

Competitive Landscape

1050 competitors in Asthma

#DrugCompanyPhaseTrials

albuterol sulfate inhalation aerosol

GSK

Phase 3

2 2

Singulair

AstraZeneca

Preclinical

17 3

Cinqair

Teva

Preclinical

13 4

Dupixent

AAzienda U.S.L. 1 di Massa e Carrara

Preclinical

30 5

Asmanex

Novartis

Preclinical

5 6

Celexa

AbbVie

Preclinical

1 7

Spiriva

Boehringer Ingelheim

Preclinical

8 8

Qvar

Chiesi Farmaceutici S.p.A.

Preclinical

8 9

Arcoxia

Aciphex

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Asthma2 trials

BE Study of Albuterol Sulfate Inhalation Aerosol 90 mcg Per Actuation in Patients With Stable Mild Asthma

Completed· Cipla logo

Cipla·Phase 3·NCT06154304·120 enrolled

4-Week Study of Efficacy, Safety and PK of Albuterol-HFA Versus Proventil-HFA in Pediatric Asthma

Terminated·AAmphastar Pharmaceuticals, Inc.·Phase 3·NCT00634517·48 enrolled

Chronic Obstructive Pulmonary Disease1 trial

Dose Finding Study of Nemiralisib (GSK2269557) in Subjects With an Acute Moderate or Severe Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)

Terminated· GSK logo

GSK·Phase 2·NCT03345407·943 enrolled

Wheezing1 trial

Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children

Completed· GSK logo

GSK·Phase 3·NCT00144846·80 enrolled

Sources

References

[1]
ClinicalTrials.gov — 4 trial records for albuterol sulfate inhalation aerosol. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — albuterol sulfate inhalation aerosol compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for albuterol sulfate inhalation aerosol. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — GSK company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: GSK

albuterol sulfate inhalation aerosol

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Asthma2 trials

Chronic Obstructive Pulmonary Disease1 trial

Wheezing1 trial

References

Drug Info

Quick Facts

Related News